Evidence map›Paper›PMID 30369101›Full record

ArticleAdvanced healthcare materials2018

Facile Engineering of Long-Term Culturable Ex Vivo Vascularized Tissues Using Biologically Derived Matrices.

Michael Hu, Amir Dailamy, Xin Yi Lei, Udit Parekh, Daniella McDonald, Aditya Kumar, Prashant Mali

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Biofabrication of engineered blood vessels for biomedical applications.Science and technology of advanced materials · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael HuDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA.
Amir DailamyDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA.
Xin Yi LeiDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA.
Udit ParekhDepartment of Electrical and Computer Engineering, University of California San Diego, La Jolla, CA, 92093, USA.
Daniella McDonaldBiomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, 92093, USA.
Aditya KumarDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA.
Prashant MaliDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA.

Funding

U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Next-generation Functional Genetic Screening of Un-screenable TraitsR01HG009285 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALI, PRASHANT, TAMAYO, PABLO · 2017 to 2020
$4.2M
Integrative Bioengineering of Heart, Vessels, and BloodT32HL105373 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHIEN, SHU, INTAGLIETTA, MARCOS · 2010 to 2019
$3.6M
Biomaterial Mimicry of Dynamic Matrix Stiffening During Tumor ProgressionR01CA206880 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ENGLER, ADAM J, YANG, JING · 2016 to 2020
$1.8M
Systematic mapping of genetic vulnerabilities in head and neck cancerR01CA222826 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALI, PRASHANT · 2018 to 2022
$1.8M
Dissecting the interplay of gene regulatory networks and cellular niche on cell fate determinationR01GM123313 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALI, PRASHANT · 2018 to 2021
$1.2M
Developing Adhesome Technology as a Physical Marker of Highly Metastatic CellsR21CA217735 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ENGLER, ADAM J · 2018 to 2020
$623k
NCI NIH HHS R01 CA206880NCI NIH HHS R01 CA222826NCI NIH HHS R21 CA217735NHGRI NIH HHS R01 HG009285NHLBI NIH HHS T32 HL105373NIGMS NIH HHS R01 GM123313NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

Recent advances in tissue engineering and 3D bioprinting have enabled construction of cell-laden scaffolds containing perfusable vascular networks. Although these methods partially address the nutrient-diffusion limitations present in engineered tissues, they are still restricted in both their viable vascular geometries and matrix material compatibility. To address this, tissue constructs are engineered via encapsulation of 3D printed, evacuable, free standing scaffolds of poly(vinyl alcohol) (PVA) in biologically derived matrices. The ease of printability and water-soluble nature of PVA grant compatibility with biologically relevant matrix materials and allow for easily repeatable generation of complex vascular patterns. This study confirms the ability of this approach to produce perfusable vascularized matrices capable of sustaining both cocultures of multiple cell types and excised tumor fragments ex vivo over multiple weeks. The study further demonstrates the ability of the approach to produce hybrid patterns allowing for coculture of vasculature and epithelial cell-lined lumens in close proximity, thereby enabling ex vivo recapitulation of gut-like systems. Taken together, the methodology is versatile, broadly applicable, and importantly, simple to use, enabling ready applicability in many research settings. It is believed that this technique has the potential to significantly accelerate progress in engineering and study of ex vivo organotypic tissue constructs.

Indexed as

BioprintingTissue EngineeringAnimalsCell Line, TumorHumansHuman Umbilical Vein Endothelial CellsIn Vitro TechniquesMiceMice, Inbred NODMice, SCIDNeoplasmsNeovascularization, PhysiologicPolyvinyl AlcoholPrinting, Three-DimensionalTissue ScaffoldsTransplantation, HeterologousPolyvinyl Alcoholbiologically derived matricesbioprintingex vivo tissuesvascularized tissues

Identifiers

PMID30369101
PMCPMC6478398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.